EICHOR
● Completed
To Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Severe Hypertriglyceridemia
Condition: Severe Hypertriglyceridemia · Sponsor: 89bio, Inc.
About this study
To determine the effect of Pegozafermin on fasting serum triglyceride levels in subjects with Severe Hypertriglyceridemia (TG ≥500 to ≤2000 mg/dL) after 26 weeks of treatment.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (177)
| 89bio Clinical Study Site | Chandler, Arizona, United States | — |
| 89bio Clinical Study Site | Peoria, Arizona, United States | — |
| 89Bio Clinical Study Site | Tucson, Arizona, United States | — |
| 89bio Clinical Study Site | Conway, Arkansas, United States | — |
| 89bio Clinical Study Site | Jonesboro, Arkansas, United States | — |
| 89bio Clinical Study Site | Little Rock, Arkansas, United States | — |
| 89bio Clinical Trial Site | Huntington Park, California, United States | — |
| 89Bio Clinical Study Site | Long Beach, California, United States | — |
| 89bio Clinical Study Site | Los Angeles, California, United States | — |
| 89bio Clinical Trial Site | Northridge, California, United States | — |
| 89bio Clinical Trial Site | Panorama City, California, United States | — |
| 89bio Clinical Study Site | Santa Ana, California, United States | — |
+ 165 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05852431